在炎症性肠道疾病中,巨细胞和肠道微生物群之间的交叉对话:影响病原和治疗的动态相互作用
Shiyang Ning1, Zhe Zhang1, Chuan Zhou1
1Department of Gastroenterology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
炎症性肠病 (IBD) 涉及肠道微生物群和称为巨细胞的免疫细胞. 了解它们的相互作用是开发IBD患者新疗法的关键.
科学领域:
- 胃肠道学和免疫学
- 微生物组研究 微生物组研究
- 细胞生物学 细胞生物学
背景情况:
- 炎症性肠病 (IBD),包括性结肠炎 (UC) 和克罗恩病 (CD),是一种慢性免疫疾病.
- IBD的发病包括遗传,环境和肠道微生物群与宿主免疫系统的相互作用.
- 肠道巨细胞对于IBD进展,平衡和组织修复至关重要.
研究的目的:
- 审查肠道巨细胞和IBD中的肠道微生物群之间的复杂关系.
- 讨论巨细胞失调,两极分化及其对肠道炎症的影响.
- 探索肠道微生物群的变化 (包括真菌和病毒),以及IBD的治疗策略.
主要方法:
- 文献综述,重点关注IBD病变发生,巨细胞生物学和肠道微生物群.
- 分析当前对微生物群和巨细胞功能的治疗作用.
- 检查新的方法,如便微生物群移植 (FMT) 和益生菌.
主要成果:
- 巨细胞失调和两极分化显著影响IBD的肠道炎症.
- IBD与肠道微生物组成和功能的改变有关,包括微生物,真菌和病毒元素.
- 目前的疗法影响微生物群和巨细胞的功能,FMT和益生菌显示出治疗潜力.
结论:
- 准肠道微生物群和巨细胞为新的IBD疗法提供了有希望的途径.
- 通过FMT或益生菌调节肠道微生物组可以改善IBD管理.
- 进一步研究微生物群和巨细胞之间的相互作用对于推进IBD治疗至关重要.
更多相关视频
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
06:57Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
